--- title: "FDA issues updated premarket cybersecurity guidance (Feb…" description: "The FDA's Feb 3, 2026 revision to 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions' is now the current…" lang: en json-ld: | [ { "@context": "https://schema.org", "@graph": [ { "@type": "WebSite", "@id": "https://medtechcybertips.com/#website", "url": "https://medtechcybertips.com/", "name": "MedTech Cyber Tips", "description": "The ultimate organized guide to medical device cybersecurity.", "inLanguage": "en-US", "publisher": { "@id": "https://medtechcybertips.com/#org" }, "potentialAction": { "@type": "SearchAction", "target": "https://medtechcybertips.com/topics?q={search_term_string}", "query-input": "required name=search_term_string" } }, { "@type": "Organization", "@id": "https://medtechcybertips.com/#org", "name": "MedTech Cyber Tips", "url": "https://medtechcybertips.com/", "logo": "https://medtechcybertips.com/icon-512.png", "sponsor": { "@type": "Organization", "name": "Blue Goat Cyber", "url": "https://bluegoatcyber.com", "sameAs": [ "https://home.bluegoatcyber.com/", "https://codebluechart.com/", "https://why.bluegoatcyber.com/", "https://spdf.bluegoatcyber.com/", "https://threatmodel.bluegoatcyber.com/", "https://pentesting.bluegoatcyber.com/", "https://premarket.bluegoatcyber.com/", "https://fdaresponse.bluegoatcyber.com/", "https://postmarket.bluegoatcyber.com/", "https://goatwatch.bluegoatcyber.com/" ] } } ] }, { "@context": "https://schema.org", "@type": "BlogPosting", "headline": "FDA issues updated premarket cybersecurity guidance (Feb 3, 2026)", "description": "The FDA's Feb 3, 2026 revision to 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions' is now the current final guidance. Here's what changed versus the 2023 edition and what to update in your submission templates.", "datePublished": "2026-02-03", "dateModified": "2026-02-03", "url": "https://medtechcybertips.com/updates/fda-premarket-cyber-guidance-feb-2026", "mainEntityOfPage": "https://medtechcybertips.com/updates/fda-premarket-cyber-guidance-feb-2026", "author": { "@type": "Person", "@id": "https://medtechcybertips.com/authors/editorial-team", "name": "MedTech Cyber Tips Editorial Team" }, "reviewedBy": { "@type": "Person", "@id": "https://medtechcybertips.com/authors/editorial-team", "name": "MedTech Cyber Tips Editorial Team" }, "publisher": { "@type": "Organization", "name": "MedTech Cyber Tips", "url": "https://medtechcybertips.com", "sponsor": { "@type": "Organization", "name": "Blue Goat Cyber" } }, "articleSection": "FDA" }, { "@context": "https://schema.org", "@type": "Person", "@id": "https://medtechcybertips.com/authors/editorial-team", "url": "https://medtechcybertips.com/authors/editorial-team", "name": "MedTech Cyber Tips Editorial Team", "jobTitle": "Medical Device Cybersecurity Editors", "description": "The MedTech Cyber Tips editorial team is a group of practitioners with hands-on experience across FDA premarket cybersecurity submissions, Secure Product Development Framework (SPDF) implementation, medical device threat modeling, and postmarket vulnerability management. Every article, checklist, and update on this site is reviewed for accuracy against the FDA's February 3, 2026 final premarket cybersecurity guidance, Section 524B of the FD&C Act, MDCG 2019-16 Rev.2, IEC 81001-5-1, ISO 14971, and the EU Cyber Resilience Act. The team also tracks 510(k) deficiency patterns and CVE trends affecting connected medical devices so guidance on the site stays current.", "knowsAbout": [ "Medical device cybersecurity", "FDA Section 524B", "FDA premarket cybersecurity guidance (Feb 3, 2026)", "Secure Product Development Framework", "SBOM and VEX", "Medical device threat modeling", "Postmarket vulnerability management", "EU MDR cybersecurity (MDCG 2019-16 Rev.2)", "EU Cyber Resilience Act", "IEC 81001-5-1", "ISO 14971 risk management" ], "sameAs": [ "https://bluegoatcyber.com/about" ], "worksFor": { "@type": "Organization", "name": "MedTech Cyber Tips", "url": "https://medtechcybertips.com/" } }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechcybertips.com" }, { "@type": "ListItem", "position": 2, "name": "Updates", "item": "https://medtechcybertips.com/updates" }, { "@type": "ListItem", "position": 3, "name": "FDA issues updated premarket cybersecurity guidance (Feb 3, 2026)", "item": "https://medtechcybertips.com/updates/fda-premarket-cyber-guidance-feb-2026" } ] } ] --- [Skip to main content](#main) [ MedTech Cyber Tips The Ultimate Guide ](/) [Home](/)[Find Your Path](/journey)[All Topics](/topics)Reference[About](/about) Search ⌘K [Updates](/updates) FDA February 3, 2026 # FDA issues updated premarket cybersecurity guidance (Feb 3, 2026) The FDA's Feb 3, 2026 revision to 'Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions' is now the current final guidance. Here's what changed versus the 2023 edition and what to update in your submission templates. Reviewed by [MedTech Cyber Tips Editorial Team](/authors/editorial-team) · Published Feb 3, 2026 · Last reviewed July 2026 On February 3, 2026, FDA issued an updated final version of its premarket cybersecurity guidance. It replaces the September 2023 edition as the current expected reference for §[524B](/glossary/524b) 'cyber device' submissions. The scaffolding is unchanged - [SPDF](/glossary/spdf), threat modeling, [SBOM](/glossary/sbom), vulnerability management, labeling, and postmarket plans remain the pillars - but several sections were tightened based on two years of submission review feedback. What to update in your submission templates: 1\. Cite the Feb 2026 guidance version in your Cybersecurity Risk Management Report, Management Plan, and Traceability sections. Reviewers now expect the current version referenced explicitly. 2\. SBOM expectations are more prescriptive: machine-readable (SPDX or CycloneDX), version-pinned, with an accompanying [VEX](/glossary/vex) for known-but-non-exploitable vulnerabilities. Free-form component lists are being cited as deficiencies. 3\. Threat model rigor: [STRIDE](/glossary/stride) plus device-specific misuse and abuse cases; AI/ML devices are expected to include adversarial ML threats (evasion, poisoning, model inversion) where applicable. 4\. Postmarket vulnerability handling: a documented [CVD](/glossary/cvd) policy is table stakes; reviewers want evidence of an operating [PSIRT](/glossary/psirt)\-style capability and a rehearsed disclosure workflow, not just a webpage. 5\. Labeling: expanded expectations for end-of-support communication and security update cadence disclosed to healthcare delivery organizations. If your device is currently mid-submission under the 2023 guidance, coordinate with your reviewer - many programs are being asked to add a short addendum aligning to the Feb 2026 version rather than restarting. Source [FDA - premarket cybersecurity guidance](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/cybersecurity-medical-devices-quality-system-considerations-and-content-premarket-submissions) More updates - [ MDCG 2019-16 Rev.2 at six months: Notified Body audit patterns Six months in, Notified Body audits under MDCG 2019-16 Rev.2 show three clear failure modes - narrative-only SBOMs, CVD policies without operational evidence, and traceability gaps between security risk controls and design outputs. Oct 2026](/updates/mdcg-2019-16-rev2-six-month-retrospective) - [ Three years of Section 524B: the deficiencies that never went away Three-year retrospective on Section 524B enforcement: SBOM depth, VEX justification, and CVD operational evidence remain the top three categories of cyber deficiencies. Two new patterns emerged in 2026 - AI/ML threat-model gaps and weak end-of-support labeling. Oct 2026](/updates/524b-three-year-checkin) - [ IEC 81001-5-1 Amendment 1 reaches FDIS - what MedTech teams should track Amendment 1 to IEC 81001-5-1 (health software security lifecycle) is in Final Draft International Standard ballot. It sharpens SBOM, CVD, and postmarket vulnerability expectations - and it's the standard EU Notified Bodies are quietly aligning MDCG 2019-16 audits against. Sep 2026](/updates/iec-81001-5-1-amendment-1-fdis) MedTech Cyber Tips The organized, end-to-end guide to medical device cybersecurity, from concept through postmarket. Part of the Blue Goat Cyber family. Topics - [Overview](/topics/home) - [Why It Matters](/topics/why) - [SPDF](/topics/spdf) - [Threat Modeling](/topics/threatmodel) - [Pentesting](/topics/pentesting) Reference - [Glossary](/glossary) - [FDA vs MDR](/compare) - [Resources](/resources) - [Updates](/updates) - [RSS feed](/rss.xml) © 2026 medtechcybertips.com. An educational resource sponsored by Blue Goat Cyber. Not legal or regulatory advice.